PMC:7075884 / 36661-36919 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1220","span":{"begin":74,"end":79},"obj":"Species"},{"id":"1225","span":{"begin":103,"end":107},"obj":"Chemical"},{"id":"1226","span":{"begin":109,"end":143},"obj":"Chemical"},{"id":"1227","span":{"begin":177,"end":187},"obj":"Chemical"},{"id":"1228","span":{"begin":188,"end":200},"obj":"Chemical"},{"id":"1229","span":{"begin":228,"end":231},"obj":"Chemical"}],"attributes":[{"id":"A1220","pred":"tao:has_database_id","subj":"1220","obj":"Tax:9606"},{"id":"A1227","pred":"tao:has_database_id","subj":"1227","obj":"MESH:D010406"},{"id":"A1228","pred":"tao:has_database_id","subj":"1228","obj":"MESH:D013307"},{"id":"A1229","pred":"tao:has_database_id","subj":"1229","obj":"MESH:D002245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The supernatants were aspirated and cells were incubated with 20 mg/mL of human serum (Sigma-H4522) in DMEM (Dulbecco’s Modified Eagle’s medium, supplemented with 5% FBS and 1% penicillin/streptomycin) for 3 days at 37 °C in 5% CO2 to allow plaque formation."}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T291","span":{"begin":36,"end":41},"obj":"Body_part"},{"id":"T292","span":{"begin":80,"end":85},"obj":"Body_part"}],"attributes":[{"id":"A291","pred":"fma_id","subj":"T291","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A292","pred":"fma_id","subj":"T292","obj":"http://purl.org/sig/ont/fma/fma63083"}],"text":"The supernatants were aspirated and cells were incubated with 20 mg/mL of human serum (Sigma-H4522) in DMEM (Dulbecco’s Modified Eagle’s medium, supplemented with 5% FBS and 1% penicillin/streptomycin) for 3 days at 37 °C in 5% CO2 to allow plaque formation."}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T15","span":{"begin":80,"end":85},"obj":"Body_part"}],"attributes":[{"id":"A15","pred":"uberon_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"The supernatants were aspirated and cells were incubated with 20 mg/mL of human serum (Sigma-H4522) in DMEM (Dulbecco’s Modified Eagle’s medium, supplemented with 5% FBS and 1% penicillin/streptomycin) for 3 days at 37 °C in 5% CO2 to allow plaque formation."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T561","span":{"begin":36,"end":41},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T562","span":{"begin":74,"end":79},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"The supernatants were aspirated and cells were incubated with 20 mg/mL of human serum (Sigma-H4522) in DMEM (Dulbecco’s Modified Eagle’s medium, supplemented with 5% FBS and 1% penicillin/streptomycin) for 3 days at 37 °C in 5% CO2 to allow plaque formation."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T854","span":{"begin":177,"end":187},"obj":"Chemical"},{"id":"T856","span":{"begin":188,"end":200},"obj":"Chemical"},{"id":"T858","span":{"begin":228,"end":231},"obj":"Chemical"}],"attributes":[{"id":"A854","pred":"chebi_id","subj":"T854","obj":"http://purl.obolibrary.org/obo/CHEBI_17334"},{"id":"A855","pred":"chebi_id","subj":"T854","obj":"http://purl.obolibrary.org/obo/CHEBI_51356"},{"id":"A856","pred":"chebi_id","subj":"T856","obj":"http://purl.obolibrary.org/obo/CHEBI_17076"},{"id":"A857","pred":"chebi_id","subj":"T856","obj":"http://purl.obolibrary.org/obo/CHEBI_58007"},{"id":"A858","pred":"chebi_id","subj":"T858","obj":"http://purl.obolibrary.org/obo/CHEBI_16526"}],"text":"The supernatants were aspirated and cells were incubated with 20 mg/mL of human serum (Sigma-H4522) in DMEM (Dulbecco’s Modified Eagle’s medium, supplemented with 5% FBS and 1% penicillin/streptomycin) for 3 days at 37 °C in 5% CO2 to allow plaque formation."}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T143","span":{"begin":248,"end":257},"obj":"http://purl.obolibrary.org/obo/GO_0009058"}],"text":"The supernatants were aspirated and cells were incubated with 20 mg/mL of human serum (Sigma-H4522) in DMEM (Dulbecco’s Modified Eagle’s medium, supplemented with 5% FBS and 1% penicillin/streptomycin) for 3 days at 37 °C in 5% CO2 to allow plaque formation."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T269","span":{"begin":0,"end":258},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The supernatants were aspirated and cells were incubated with 20 mg/mL of human serum (Sigma-H4522) in DMEM (Dulbecco’s Modified Eagle’s medium, supplemented with 5% FBS and 1% penicillin/streptomycin) for 3 days at 37 °C in 5% CO2 to allow plaque formation."}